The objective of this contract is to support the NIAID in its mission to develop safe and effective therapies for the treatment of infectious diseases caused by Human Immunodeficiency Virus (HIV), Mycobacterium tuberculosis, Plasmodium sp., opportunistic pathogens that infect AIDS patients, and others. The NIAID requires a Safety Evaluation Contract to assess the health and safety potential of new therapies under development by, or with the support of, the Division of AIDS, NIAID. The scope of this effort is to evaluate the toxicity and pharmacokinetics of potential chemical and biological therapies for AIDS and other infectious diseases in various laboratory animal species.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272200700043C-6-0-1
Application #
8730056
Study Section
Project Start
2007-09-30
Project End
2014-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$2,414,000
Indirect Cost
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025